Natural Products as Sources of New Drugs from 1981 to 2014.
about
Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal MedicineStructural basis for precursor protein-directed ribosomal peptide macrocyclizationChiral Alkyl Halides: Underexplored Motifs in MedicineDiscovery of Anticancer Agents of Diverse Natural OriginLead Discovery Strategies for Identification of Chlamydia pneumoniae InhibitorsThe Pharmacological Potential of Non-ribosomal Peptides from Marine Sponge and TunicatesDiscovery of Bioactive Compounds by the UIC-ICBG Drug Discovery Program in the 18 Years Since 1998Discovery and development of natural product oridonin-inspired anticancer agentsPrenylated Polyphenols from Clusiaceae and Calophyllaceae with Immunomodulatory Activity on Endothelial CellsAntioxidant, Antimicrobial and Cytotoxic Properties as Well as the Phenolic Content of the Extract from Hancornia speciosa GomesGenomic charting of ribosomally synthesized natural product chemical space facilitates targeted miningThe Chemical Profile of Senna velutina Leaves and Their Antioxidant and Cytotoxic EffectsAntiproliferative and anti-inflammatory polyhydroxylated spirostanol saponins from Tupistra chinensisElucidating the Rimosamide-Detoxin Natural Product Families and Their Biosynthesis Using Metabolite/Gene Cluster Correlations.Enhanced dereplication of fungal cultures via use of mass defect filtering.β-Sitosterol Reduces the Expression of Chemotactic Cytokine Genes in Cystic Fibrosis Bronchial Epithelial Cells.Screening and identification of novel biologically active natural compounds.Anti-allergic Hydroxy Fatty Acids from Typhonium blumei Explored through ChemGPS-NP.Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Biosynthesis of Fluorinated Peptaibols Using a Site-Directed Building Block Incorporation Approach.Biological Significance of Marine Actinobacteria of East Coast of Andhra Pradesh, India.The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo.Identification of 1,2,3,4,6-Penta-O-galloyl-β-d-glucopyranoside as a Glycine N-Methyltransferase Enhancer by High-Throughput Screening of Natural Products Inhibits Hepatocellular Carcinoma.Annona species (Annonaceae): a rich source of potential antitumor agents?Twelve-membered macrolactones: privileged scaffolds for the development of new therapeutics.Screening of a virtual mirror-image library of natural products.Exploitation of Fungal Biodiversity for Discovery of Novel Antibiotics.Fraxinus xanthoxyloides leaves reduced the level of inflammatory mediators during in vitro and in vivo studiesLinker Flexibility Facilitates Module Exchange in Fungal Hybrid PKS-NRPS Engineering.Natural Product Screening Reveals Naphthoquinone Complex I Bypass Factors.Discovery of MRSA active antibiotics using primary sequence from the human microbiome.Natural products as mediators of disease.Urban park soil microbiomes are a rich reservoir of natural product biosynthetic diversityGenes Linked to Production of Secondary Metabolites in Talaromyces atroroseus Revealed Using CRISPR-Cas9.Madurastatin B3, a rare aziridine derivative from actinomycete Nocardiopsis sp. LS150010 with potent anti-tuberculosis activity.Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis.Endophytic actinomycetes: promising source of novel bioactive compounds.Using natural products for drug discovery: the impact of the genomics era.Natural product discovery from the human microbiome.Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A.
P2860
Q26741336-BAEDCDF0-8EBC-43B7-89ED-8A800D283ED5Q27728118-3C9DFCAF-7491-44A5-A5F1-C4F82B0F27B0Q28066955-F7999A89-21C2-44C7-A2EA-722DE3D3D872Q28068341-E1C754CE-EEB7-4AA0-BD16-49EAE7C9F143Q28069433-16D3574E-B1A3-49DD-BF55-2BD9062C9BBCQ28074153-C0EA4117-6BFD-4165-9408-D0A81060EB13Q28075313-1C3ABB9A-0E03-4603-AA64-C59984704BC9Q28387804-155A6FBA-DEFF-41BF-9183-32BB11CE865DQ28554642-BA02F896-0263-4FBA-8241-568961D445F5Q28554670-4A5D18DD-3347-470E-9938-597FA850B66CQ28820976-7E475074-A0EA-4D3C-ACEB-3E7A6E2631A0Q28821302-A50A1D92-31E9-4588-A7AE-000342568966Q28830126-8CF435C7-8489-4C21-83A3-053392EE9E04Q31140705-F93845BE-F7DB-4AA8-A258-8DA05C9E205AQ33611257-E6739DDB-DB8E-4E4A-AEFF-AFE646380C13Q33665738-48B7C7EE-391C-4777-B54C-CEFABDCC81C6Q33777835-06BED520-34D1-4B18-B495-66991BCCFE6DQ33809681-AD8CA6F1-9E1F-4F5E-A6FD-1E2088CDEC40Q33834080-20655540-2D37-46C4-B27B-DE117E8854F1Q33836344-1B11FC7A-8755-45D2-AA3C-0421C2B0A197Q33875599-D8EC3447-56B4-4037-9DAD-4E3060F89CB8Q33922498-4F3C1F02-2411-4273-932B-DB243AA31FFAQ34525464-D12C0CC1-8F2C-4414-845F-EEAAAFF99711Q34555315-3EFB8C83-7176-413C-BE69-5956D9E972BFQ36011215-07F07F0D-CD87-4EAD-B6E3-35DD4391579DQ36023171-E68B4BA6-60A7-4090-9C4C-0ED6B0CE74E3Q36079283-5223A853-EC56-4E6A-AE39-6E3DA5F4825EQ36080677-FA84FEA9-AD9A-4229-8866-F5560F172938Q36110113-4896DDEC-6877-4E75-85CB-C789AB526A42Q36131234-680620A1-3344-4AE3-BD3E-9D7E1F30B74CQ36164942-D6269C31-D9E3-44F9-AFBB-07401FA41B65Q36200942-BFA6E97A-9709-44D4-8033-C28A63C1BE1AQ36211781-DCFE704B-5221-4450-BCEE-A3BCC393C3CFQ36240411-8CF04F3C-BACC-4AF4-9949-439415B725BAQ36274891-CEDE1509-13E4-4334-BB05-9BC2495660C0Q36287725-BA22F31E-6185-4FF8-8155-F81EA9A1CF6AQ36300214-70D18D30-5CDC-498D-9E60-41CB500C0460Q36302104-A43D95CB-F3AA-4C50-8CF1-D014CD9CB0A4Q36340566-7337488E-93F8-49B3-AFF2-113669CC6AE0Q36359184-885D3DF7-FBBD-4394-B850-48DE90C6FDDF
P2860
Natural Products as Sources of New Drugs from 1981 to 2014.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Natural Products as Sources of New Drugs from 1981 to 2014.
@ast
Natural Products as Sources of New Drugs from 1981 to 2014.
@en
Natural Products as Sources of New Drugs from 1981 to 2014.
@nl
type
label
Natural Products as Sources of New Drugs from 1981 to 2014.
@ast
Natural Products as Sources of New Drugs from 1981 to 2014.
@en
Natural Products as Sources of New Drugs from 1981 to 2014.
@nl
prefLabel
Natural Products as Sources of New Drugs from 1981 to 2014.
@ast
Natural Products as Sources of New Drugs from 1981 to 2014.
@en
Natural Products as Sources of New Drugs from 1981 to 2014.
@nl
P1476
Natural Products as Sources of New Drugs from 1981 to 2014.
@en
P2093
David J Newman
Gordon M Cragg
P304
P356
10.1021/ACS.JNATPROD.5B01055
P577
2016-02-07T00:00:00Z